The global Sleep Apnea Diagnostic Systems Market has reached a valuation of USD 4.81 billion in 2023, with a projected CAGR of 6.8% from 2023 to 2033. By 2033, the market is anticipated to reach USD 9.27 billion.
Working in shifts and stressful work environments cause sleep apnea, and various technological advancements in sleep apnea diagnostics devices are driving the growth of the global market for sleep apnea diagnostic systems.
Sleep apnea diagnostic systems face challenges from high costs and limited awareness, yet untapped opportunities in developing economies hold promise.
| Attribute | Details |
|---|---|
| Sleep Apnea Diagnostic Systems Market Estimated Value (2023) | USD 4.81 billion |
| Sleep Apnea Diagnostic Systems Market Estimated Value (2033) | USD 9.27 billion |
| Sleep Apnea Diagnostic Systems Market Value CAGR (2023 to 2033) | 6.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The sleep apnea diagnostic systems market is mainly driven by increasing cases of sleep disorders and lifestyle disorders such as cardiovascular diseases, diabetes, obesity, and depression.
As per the FMI’s analysis, the global sleep apnea diagnostic systems demand was anticipated to reach a valuation of USD 3.42 billion with a CAGR of 5.7% from 2018 to 2022.
With the healthcare industry tapping into next-generation technologies while assisting the development of advanced oral sleep apnea diagnostic systems, the market is anticipated to gain momentum over the forecast period.
Burgeoning demand for advanced polysomnography (PSG) devices within hospitals and sleep centers encourage the adoption of PSG devices and sleep apnea diagnostic systems over the coming years.
Other trends that are propelling the growth are rising favorable government initiatives, private organizations’ increased investment, and the rising prevalence of cardiovascular diseases and diabetes across the globe.
Lack of awareness about sleep disorders and social stigma related to mental health issues and sleep disorders are likely to limit the growth of sleep apnea diagnostic systems market.
However, with the increasing penetration of advanced technology coupled with the rising cases of undiagnosed and untreated sleep apnea, the demand for sleep apnea diagnostic systems likely accelerates over the coming years.
Based on these aforementioned factors, the market has been forecasted to exhibit steady growth, registering a CAGR of over 6.8% during the forecast period.
Principal Consultant
This collaborative approach enhances market growth by addressing the needs of the undiagnosed sleep apnea patient population.
Rising incidence of sleep disorders such as sleep apnea, sleep walking and others have improved the adoption of sleep apnea diagnostic systems across the United States of America.
As per Future Market Insights, the market in the United States of America is anticipated to be a highly lucrative market during the forecast period, with a value share of 48.0% in 2022.
As cases of cardiovascular diseases, diabetes, and other lifestyle disorders are surging, prevalence of sleep apnea is expected to soar simultaneously.
Due to the rising burden of various healthcare concerns, adoption of sleep apnea diagnostic systems has surged across the United States of America. Favorable government policies, and investments for the development of advanced diagnostic systems further the adoption over the coming years.
According to FMI, the China market is expected to witness impressive growth rate of 7.4% from 2023 to 2033 due the technological advancements in the healthcare sector. Demand for PSG devices is expected to surge in China due to the rising cases of sleep apnea.
The incidence of diabetes, anxiety, depression, and other diseases is on the rise, which has raised the risk of sleep disorders in patients. Due to this, the adoption of advanced PSG devices for the diagnosis of sleep apnea has increased across healthcare facilities in China.
The sales of sleep apnea diagnostic systems in India are supported by several unique factors that are facilitating the country’s anticipated growth rate of 6.7% from 2023 to 2033.
The increasing awareness among the general population and healthcare professionals about sleep disorders and their consequences have led to a greater demand for diagnostic systems.
The expansion of healthcare infrastructure and the availability of advanced technology in urban areas have made sleep apnea diagnostic systems more accessible to patients across the country.
Market growth is also fostered by the growing focus on preventive healthcare and early diagnosis that has spurred the adoption of these systems, promoting sales in the Indian market.
The growing adoption of telemedicine and digital health platforms in India has played a significant role in supporting the sales of sleep apnea diagnostic systems.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Actigraphy monitoring devices are highly sought-after due to their non-invasive nature and ability to provide objective and long-term data on sleep and activity patterns.
These devices offer a convenient and comfortable way to gather accurate information without disrupting an individual's sleep routine.
The market demand for actigraphy monitoring devices is driven by the growing awareness and recognition of the importance of sleep health, fostering the sub-segments value share of 39.68% in 2022.
Sleep disorders have become a global health concern, leading to an increased need for reliable and efficient methods of assessing sleep patterns.
Actigraphy devices provide an objective assessment of sleep parameters, such as sleep duration and efficiency, which helps clinicians and researchers identify sleep disorders, evaluate treatment outcomes, and monitor sleep patterns over time.
The adoption of sleep apnea diagnostic systems is anticipated to remain the maximum at sleep centers and clinics during the forecast period. As per Future Market Insights, sleep centers and clinics segment is expected to account for over 38.93% of the global market share.
Due to the rising incidence of sleep apnea across the globe, patients prefer sleep centers and clinics as they’re equipped with all the analysis and diagnostic systems. However, a shift in preference towards home sleep testing (HST) devices is expected to present new growth opportunities from the at-home care setting segment over the coming years.
FMI projects rapid growth of the sleep apnea diagnostic systems market from hospitals, driven by the high adoption of these systems for in-lab testing. Furthermore, the sleep apnea diagnostic system is anticipated to witness impressive traction in home care settings.
Prominent players operating in the sleep apnea diagnostic systems market are focusing on product innovation and introduction to increase their sales. As per FMI, Koninklijke Philips N.V. and ResMed Inc. are the leading players dominating the market.
Leading players continue to address the unmet needs in the market through inorganic strategies such as mergers and acquisitions.
Increasing research & development activities for the development of advanced sleep apnea diagnostic systems likely open up lucrative opportunities for market players.
Strategies by Players:
Developments in the Market:
Technological advancements in the healthcare sector are growing the demand in China.
The market is likely to reach USD 9.27 billion by 2033.
The growing prevalence of untreated sleep apnea is driving the market growth.
The market captured 5.7 CAGR between 2018 and 2022.
The sleep centers and clinics sector is likely to hold high revenue potential.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1 Polysomnography (PSG) Devices 5.1.1. Ambulatory PSG Monitoring Devices 5.1.2. Clinical PSG Monitoring Devices 5.1.3. Sleep Apnea Screening Device 5.2 Nasal Flow Sensors 5.3 Peripheral Capillary Oxygen Saturation (SPO2) 5.4 Actigraphy Monitoring Devices 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User Type 6.1 Home Care Settings 6.2 Hospitals 6.3 Sleep Centers & Clinics 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1 North America 7.2 Latin America 7.3 Western Europe 7.4 Eastern Europe 7.5 South Asia and Pacific 7.6 East Asia 7.7 Middle East and Africa 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1 Koninklijke Philips N.V. 17.2 Becton, Dickinson and Company 17.3 Braedon Medical Corporation 17.4 Advanced Brain Monitoring Inc. 17.5 SOMNOmedics GmbH 17.6 ResMed Inc. 17.7 BMC Medical Co. Ltd. 17.8 Natus Medical Incorporated 17.9 MGC Diagnostics Corporation 17.10 Cleveland Medical Devices Inc. 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Sleep Apnea Diagnostic Systems Market
